Medscape

Medscape InDiscussion: CAR T-Cell Therapy

Listen to Medscape InDiscussion: CAR T-Cell Therapy, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987065). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Bezoek zeker de website van de podcast en steun de maker: www.medscape.com

Auteur

Medscape

Categorie

Science

Website van de podcast

www.medscape.com

Nieuwste aflevering

12 sep. 2023

Waar luisteren?

Podcasts in de app Replaio Radio Binnenkort beschikbaar

Podcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts

Download het op Google Play Gratis installeren Android bijna 10 mln downloads · beoordeling 4,8 iOS binnenkort

Afleveringen

The Future of CAR T-cell Therapy 12.09.2023

Join Drs Amelia Langston and Frederick Locke as they discuss the future of CAR T-cell therapy research and treatment. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987070). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resou...

CAR T-Cell Therapy for Multiple Myeloma 10.08.2023

Join Drs Amelia Langston and Jonathan L. Kaufman, MD, as they discuss current CAR–T cell for B-cell lymphomas as leading researchers and practitioners in the field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987069). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is inten...

CAR T-Cell Therapy for B-Cell Lymphomas 11.07.2023

Join Drs Amelia Langston and Loretta Nastoupil as they discuss current CAR T-cell therapy for B-cell lymphomas as leading researchers and practitioners in the field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987068). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is inte...

CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia 13.06.2023

Join Drs Amelia Langston and Bijal Shah as they discuss CAR T-cell therapy for B-cell acute lymphoblastic leukemia, including clinical trials and real-world experience from their centers. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987067). The topics and discussions are planned, produced, and reviewed independently of advertisers...

Monitoring and Management of CAR T-Cell Therapy Complications 11.05.2023

Join Drs Amelia Langston and Jean Koff as they discuss the monitoring and management of complications before, during, and after CAR T therapy. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987066). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US health...

When Is CAR T-Cell Therapy the Answer? 11.05.2023

Drs Amelia Langston and Melody Smith provide an overview of CAR T-cell therapy, the products available, potential complications, and what's next in this rapidly advancing field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987065). The topics and discussions are planned, produced, and reviewed independently of advertisers. This pod...

Luister naar de podcast Medscape InDiscussion: CAR T-Cell Therapy in Replaio

Radio en podcasts in één app - gratis en zonder account. Installeer vandaag nog en mis de lancering niet

Download het op Google Play

Replaio is geen uitgever van podcasts; namen van shows, covers en audio zijn eigendom van hun makers en worden verspreid via openbare RSS-feeds